Micro
RNA
is expected to be a novel therapeutic tool for tumors. Gap junctions facilitate the transfer of micro
RNA
, which exerts biological effects on tumor cells. However, the length of micro
RNA
that can pass through certain gap junctions composed of specific connexin remains unknown. To address this question, the present study investigated the permeability of gap junctions composed of various connexins, including connexin 43, connexin 32 or connexin 37, to micro
RNA
s consisting of 18‐27 nucleotides in glioma cells and cervical cancer cells. Results indicated that all of the micro
RNA
s were able to be transferred from donor glioma cells to neighboring cells through the connexin 43 composed gap junction, but not the gap junctions composed of connexin 32 or connexin 37, in cervical cancer cells. Downregulation of the function of gap junctions comprising connexin 43 by pharmacological inhibition and sh
RNA
significantly decreased the transfer of these micro
RNA
s. In contrast, gap junction enhancers and overexpression of connexin 43 effectively increased these transfers. In glioma cells, cell proliferation was inhibited by micro
RNA
‐34a. Additionally, these effects of micro
RNA
‐34a were significantly enhanced by overexpression of connexin 43 in U251 cells, indicating that gap junctions play an important role in the antitumor effect of micro
RNA
by transfer of micro
RNA
to neighboring cells. Our data are the first to clarify the pattern of micro
RNA
transmission through gap junctions and provide novel insights to show that antitumor micro
RNA
s should be combined with connexin 43 or a connexin 43 enhancer, not connexin 32 or connexin 37, in order to improve the therapeutic effect.